Phase 2a clinical study in mild-to-moderate psoriasis initiating in December 2022 PRINCETON, N.J., Oct. 25, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today the formation of… Read More..

- Regulatory Milestones Improve Path to Filing a European Marketing Authorization Application - - Company Plans to Submit Additional Application for Orphan Designation in Europe for TMB-001 for the Treatment of X-Linked Recessive Ichthyosis - BASKING RIDGE, NJ, Oct. 25, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc.… Read More..

TEL AVIV, Israel , Oct. 21, 2022 /PRNewswire/ -- SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-Government, IoT and Cybersecurity sectors, will hold a conference call on Wednesday, October 26, 2022, at 9:00 a.m. Eastern time (6:00 a.m. Pacific Time / 4:00 p.m. IL time) to discuss its financial… Read More..